Gossamer Bio, Inc. financials

GOSS CIK 0001728117

Source: EDGAR filings · Built 2026-06-02T03:09:17Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -171.34M -3.47M -159.16M -187.44M -190.44M -177.86M
EBITDA -170.70M -59.09M -182.15M -216.76M -214.38M -232.55M
Working Capital 104.21M 264.88M 254.92M 212.65M 291.92M 483.67M
Net Debt -33.33M -40.72M -16.24M -81.94M -148.20M -445.96M
Operating Margin -352.23% -52.24%
Net Margin -351.49% -49.28%
Return on Equity (ROE) 138.78% -191.67% -286.47% -1899.30% -192.65% -75.89%
Return on Assets (ROA) -98.91% -17.93% -57.65% -84.19% -68.09% -45.11%
Current Ratio 2.64× 6.88× 5.94× 5.32× 8.32× 13.51×
Debt-to-Equity -0.04× 0.18× 0.25× 2.49× 0.29× 0.13×
Effective Tax Rate 0.05% -1.61% 0.00% 0.00%
Cash Conversion Ratio 1.01× 0.06× 0.89× 0.82× 0.81× 0.72×
Accruals Ratio 0.01× -0.17× -0.07× -0.16× -0.13× -0.12×
SBC % of Revenue 21.78% 17.98%
CapEx Coverage -2167.92× -456.18× -122.18× -117.34×
Free Cash Flow Per Share $-0.75 $-0.02 $-1.04 $-2.22 $-2.54 $-2.60

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 48.47M 114.70M 0 0
Operating Expenses 219.20M 174.62M 183.76M 218.59M 216.12M 233.96M
Operating Income (Loss) -170.73M -59.92M -183.76M -218.59M -216.12M -233.96M
Income Tax Expense (Benefit) -88.00K 893.00K 0 0
Net Income (Loss) Attributable to Parent -170.37M -56.53M -179.82M -229.38M -234.00M -243.36M
Earnings Per Share, Basic $-0.75 $-0.25 $-1.18 $-2.71 $-3.13 $-3.55
Weighted Average Number of Shares Outstanding, Basic 228.52M 226.23M 152.62M 84.57M 74.84M 68.51M
Earnings Per Share, Diluted $-0.75 $-0.25 $-1.18 $-2.71 $-3.13 $-3.55
Weighted Average Number of Shares Outstanding, Diluted 228.52M 226.23M 152.62M 84.57M 74.84M 68.51M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 37.73M 46.07M 32.11M 111.97M 183.40M 486.06M
Assets, Current 167.64M 309.89M 306.52M 261.88M 331.78M 522.32M
Assets 172.25M 315.29M 311.92M 272.45M 343.66M 539.43M
Liabilities, Current 63.44M 45.01M 51.60M 49.23M 39.86M 38.65M
Long-term Debt, Excluding Current Maturities 0 814.00K 11.99M 29.08M 28.74M
Liabilities 295.01M 285.80M 249.15M 260.37M 222.19M 218.75M
Stockholders' Equity Attributable to Parent -122.76M 29.49M 62.77M 12.08M 121.46M 320.68M
Common Stock, Shares, Outstanding 233.68M 226.60M 225.41M 94.42M 75.75M 73.87M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -171.27M -3.47M -159.16M -187.03M -188.89M -176.36M
Payments to Acquire Property, Plant, and Equipment 79.00K 0 0 410.00K 1.55M 1.50M
Net Cash Provided by (Used in) Investing Activities 156.36M 29.02M -110.97M -1.03M -117.43M 215.34M
Net Cash Provided by (Used in) Financing Activities 6.42M -11.49M 190.15M 117.09M 3.33M 312.54M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (GOSS CIK 0001728117), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CBT

Cabot Corporation

KROS

KEROS THERAPEUTICS, INC.

SPHR

SPHERE ENTERTAINMENT CO.